Investors Business Daily: Vaccine manufacturing challenge

GreenLight CEO, Andrey Zarur, speaks to for Investor’s Business daily about the challenge of vaccine manufacturing for Covid-19.

vaccine manufacturing
Credit: Elizabeth Plumb/shutterstock.com

GreenLight CEO, Andrey Zarur, spoke to Investor’s Business Daily about the Covid-19 vaccine manufacturing challenge, with billions around the world in need. In the article, he said:

“The question that you ask becomes really, really relevant when we are trying to vaccinate a couple billion people… There’s no way to do that in a day. There’s just not enough infrastructure to go out and vaccinate 100 million people a day. That’s not going to happen. So, how do we deal with that?”

“You need two doses and that’s going to be a problem… Imagine getting one dose to Appalachia, a rural community. Now imagine having to come back and making sure everyone who got the first dose also gets the second one. That’s a challenge.”

“Also key is eventual approval of next-generation coronavirus vaccines… That second generation will give us options.”

Read the full article >

Find out more about how GreenLight manufactures RNA.